NCT03306888

Brief Summary

This study will evaluate the feasibility and acceptability of a clinic-based physical activity coaching intervention in people with pre-manifest and early stage Huntington's Disease (HD). Fourteen individuals with premanifest and early stage HD will be recruited to participate in a 4 month coaching intervention. Feasibility will be assessed by recruitment and retention rates, and acceptability will be assessed by participant interviews. Participants will also be evaluate at baseline and following the coaching intervention to explore preliminary efficacy in terms of physical activity, self efficacy, disease-specific motor and cognitive function, walking endurance and strength.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Oct 2017

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 2, 2017

Completed
8 days until next milestone

Study Start

First participant enrolled

October 10, 2017

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 11, 2017

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
Last Updated

May 30, 2019

Status Verified

November 1, 2018

Enrollment Period

1.5 years

First QC Date

October 2, 2017

Last Update Submit

May 29, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in physical activity (daily step counts) at 4 months

    Physical activity as measured by waist worn device (Actigraph)

    4 months

Secondary Outcomes (8)

  • Change in International Physical Activity Questionnaire (IPAQ) metabolic equivalent of task at 4 months

    4 months

  • Change in Lorig self efficacy scale at 4 months

    4 months

  • Change in 6 minute walk distance at 4 months

    4 months

  • Change in grip strength at 4 months

    4 months

  • Change in HD-PRO-TRIAD at 4 months

    4 months

  • +3 more secondary outcomes

Study Arms (1)

Physical Activity Coaching Intervention

EXPERIMENTAL

The intervention will entail one face-to-face coaching session (approximately 1 hour) to be held approximately 1 week following the baseline assessment, and three remote video sessions (via secure Webex connection via computer or smart phone, or phone call if internet/smart phone is not available to participant) lasting approximately 20 minutes.

Other: Physical Activity Coaching

Interventions

Physical activity coaching over 4 months

Physical Activity Coaching Intervention

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • For premanifest - Confirmatory genetic testing for Huntington disease (HD) and diagnostic confidence score of 0-3 on Unified Huntington Disease Rating Scale, indicating pre-manifest disease state. For manifest HD - Confirmatory genetic testing for HD or confirmed clinical diagnosis of HD by neurologist
  • Successful completion of Physical Activity Readiness Questionnaire (PAR-Q), or medical clearance from General Practioner
  • For potential participants over age 60, a minimum score of 24 on the Mini-Mental State Examination (MMSE) (completed within 3 months) will be required for capacity to consent.
  • For potential participants age 60-65, successful pass of electrocardiogram screen will be required.

You may not qualify if:

  • Musculoskeletal injury that would interfere with participation in an exercise program
  • Currently participating in a structured exercise program 3 times per week or more
  • Uncontrolled psychiatric or behavioral problems that would interfere with participation in an exercise program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Columbia University

New York, New York, 10027, United States

Location

MeSH Terms

Conditions

Huntington Disease

Condition Hierarchy (Ancestors)

Basal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesDementiaChoreaDyskinesiasMovement DisordersHeredodegenerative Disorders, Nervous SystemNeurodegenerative DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesCognition DisordersNeurocognitive DisordersMental Disorders

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Single arm feasibility study with 14 participants
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2017

First Posted

October 11, 2017

Study Start

October 10, 2017

Primary Completion

April 1, 2019

Study Completion

April 1, 2019

Last Updated

May 30, 2019

Record last verified: 2018-11

Locations